NR0B1 and neoplasm: When comparing the plasma concentration ratios, we observed that the R954-treated group showed significant decreases in tumour-to-plasma ratios (30% and 69% reduction at 1 h and 4 h after injection, respectively), indicating the specific accumulation of [111In]In-DOTA-Ahx-R954 in tumours.